Endocrinological evaluation of dawn phenomenon in patients with diabetes and comparison of insulin glargine U-100 biosimilar (Insulin Glargine BS Injection Lilly) and glargine U-300 (Lantus XR): a randomized controlled study

Hasebe, M; Satoh, S; Ito, K; Tamura, H; Terauchi, Y

Satoh, S (通讯作者),Chigasaki Municipal Hosp, Metab Internal Secret Internal Med, 5-15-1 Honson, Chigasaki, Kanagawa 2530042, Japan.

ENDOCRINE JOURNAL, 2023; 70 (8): 777

Abstract

We investigated the pathophysiology of the dawn phenomenon by examining the effects of changes in blood glucose levels from late night to early mornin......

Full Text Link